The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / September / Can Anti-Inflammatories Slow Myopia?
Refractive Pediatric Opinions

Can Anti-Inflammatories Slow Myopia?

New clinical evidence links systemic inflammation to childhood myopia, suggesting anti-inflammatory treatment could delay progression

By Jody Summers , R. Michael Siatkowski 9/21/2026 1 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Quiz
  • Poll
  • Topic Commentary

Clinical Report: Can Anti-Inflammatories Slow Myopia?

Overview

A study presented at ARVO 2026 indicates that systemic inflammation may contribute to childhood myopia progression. Treatment with systemic anti-inflammatory medications was associated with slower myopia progression and delayed onset in affected children, but these findings are preliminary.

Background

Myopia is a growing global concern, particularly in children, as it is linked to serious ocular complications later in life. Current treatments, such as low-dose atropine, have uncertain long-term efficacy. Understanding the role of inflammation in myopia could provide insights into its progression.

Data Highlights

GroupMyopia Progression (D/year)Onset Age (years)
Untreated JIA0.2310.19
Treated JIA0.1217.51
Control0.2310.19

Key Findings

  • Children with untreated juvenile idiopathic arthritis (JIA) were more myopic than controls.
  • Systemic anti-inflammatory therapy was linked to less myopia in older patients.
  • Patients receiving therapy had a slower rate of myopia progression (0.12 D/year).
  • Onset of myopia was delayed in treated patients (17.51 years) compared to untreated controls.
  • Inflammatory mediators may influence ocular growth and refractive development.

Clinical Implications

The findings indicate that systemic inflammation may play a role in myopia progression. However, the study's retrospective design and limitations warrant cautious interpretation of the results.

Conclusion

This study provides evidence linking systemic inflammation to myopia progression. Further research is needed to validate these findings.

Related Resources & Content

  1. University of Oklahoma College of Medicine, ARVO, 2026 -- Can Anti-Inflammatories Slow Myopia?
  2. IMI Interventions for Controlling Myopia Onset and Progression 2025 - Myopia Institute
  3. Low-Dose Atropine and Other Interventions for Pediatric Myopia: A Systematic Review and Bayesian Network Meta-analysis of Efficacy and Post-treatment Outcomes | Ophthalmology and Therapy | Springer Nature Link
  4. MDSpire News — Does Exercise Inhibit Myopia Progression in Children?
  5. mdspire news — Does Exercise Inhibit Myopia Progression in Children?
  6. Eyecare Business — Does Exercise Inhibit Myopia Progression in Children? Recommendations
  7. Contact Lens Spectrum — RED LIGHT: A STOP SIGNAL FOR MYOPIA PROGRESSION?
  8. Does Exercise Inhibit Myopia Progression in Children?
  9. Does Exercise Inhibit Myopia Progression in Children? Recommendations
  10. IMI Interventions for Controlling Myopia Onset and Progression 2025 - Myopia Institute
  11. Low-Dose Atropine and Other Interventions for Pediatric Myopia: A Systematic Review and Bayesian Network Meta-analysis of Efficacy and Post-treatment Outcomes | Ophthalmology and Therapy | Springer Nature Link
  12. ARVO2026 Recap #4 – Can we prevent myopia in children & treat it in adults? | Myopia Profile

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: